Filing Flows › Invo Fertility (IVF) › Q1 2025
Invo Fertility (IVF) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 20, 2025
Invo Fertility (IVF) reported revenue of $1.6M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -3% from the quarter before.
Invo Fertility, Q1 2025: revenue $1.6M (+4% year over year), net loss $17.4M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -3% | +4% |
| Operating profit | −$17.1M | — | — |
| Net earnings | −$17.4M | -478% | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $1.6M in Q1 2025, up 4% year over year and down 3% from the previous quarter. Clinic Revenue was the largest line at 99% of revenue. Clinic Revenue added $84K year over year (up 5%), 139% of the total change. Product declined 60%.
Operating costs exceeded revenue by $17.1M, an operating margin of -1044.9%. Total costs grew 508% against revenue growth of 4%. The fastest-growing cost line was Research & development (+5344%). The quarter ended with a net loss of $17.4M, after a profit of $4.6M the previous quarter.
Operating cash flow was −$3.5M. Non-cash charges added back $234K of depreciation and amortization. Working capital and other items added $13.6M. Capital expenditures of $15K exceeded it, leaving free cash flow of −$3.6M.
Questions
What was Invo Fertility's revenue in the first quarter 2025?
Invo Fertility (IVF) reported revenue of $1.6M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -3% from the quarter before.
Source: Invo Fertility 10-Q on SEC EDGAR.